CD抗原がん療法のグローバル市場調査 2019年

• 英文タイトル：Global CD Antigen Cancer Therapy Market Professional Survey Report 2019

• レポートコード：QYR9NV02343
• 出版社/出版日：QYResearch / 2019年11月12日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、110ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・ヘルスケア

• 販売価格（消費税別）

Single User	￥525,000 (USD3,500)	▷ お問い合わせ
Enterprise License	￥1,050,000 (USD7,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートは、CD抗原がん療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、モノクローナル抗体、抗体薬物複合体、三機能性および二重特異性T細胞エンゲージ抗体、その他、に、用途別には、病院、診療所、その他にセグメント区分し、CD抗原がん療法の世界市場を分析しました。

・エグゼクティブ・サマリー
・CD抗原がん療法の世界市場概要
・CD抗原がん療法の製造コスト構成分析
・CD抗原がん療法の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・CD抗原がん療法の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・CD抗原がん療法のセグメント分析（種類別）
（モノクローナル抗体、抗体薬物複合体、三機能性および二重特異性T細胞エンゲージ抗体、その他、）
・CD抗原がん療法のセグメント分析（用途別）
（病院、診療所、その他）
・CD抗原がん療法の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（AryoGen Biopharma、Biocad、Biogen Idec、Celltrion、Genentech、Genmab、GLYCART Biotechnology、Hetero Drugs、mAbxience、MedImmune、Merck、Sandoz、UCB、）
・CD抗原がん療法の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

The global CD Antigen Cancer Therapy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on CD Antigen Cancer Therapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall CD Antigen Cancer Therapy market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of CD Antigen Cancer Therapy in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their CD Antigen Cancer Therapy manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AryoGen Biopharma
Biocad
Biogen Idec
Celltrion
Genentech
Genmab
GLYCART Biotechnology
Hetero Drugs
mAbxience
MedImmune
Merck
Sandoz
UCB

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Monoclonal Antibodies
Antibody-Drug-Conjugates
Tri-Functional and Bi-Specific T-Cell Engager Antibodies
Other

Segment by Application
Hospitals
Clinics
Other

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of CD Antigen Cancer Therapy
1.1 Definition of CD Antigen Cancer Therapy
1.2 CD Antigen Cancer Therapy Segment by Type
1.2.1 Global CD Antigen Cancer Therapy Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Monoclonal Antibodies
1.2.3 Antibody-Drug-Conjugates
1.2.4 Tri-Functional and Bi-Specific T-Cell Engager Antibodies
1.2.5 Other
1.3 CD Antigen Cancer Therapy Segment by Applications
1.3.1 Global CD Antigen Cancer Therapy Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global CD Antigen Cancer Therapy Overall Market
1.4.1 Global CD Antigen Cancer Therapy Revenue (2014-2025)
1.4.2 Global CD Antigen Cancer Therapy Production (2014-2025)
1.4.3 North America CD Antigen Cancer Therapy Status and Prospect (2014-2025)
1.4.4 Europe CD Antigen Cancer Therapy Status and Prospect (2014-2025)
1.4.5 China CD Antigen Cancer Therapy Status and Prospect (2014-2025)
1.4.6 Japan CD Antigen Cancer Therapy Status and Prospect (2014-2025)
1.4.7 Southeast Asia CD Antigen Cancer Therapy Status and Prospect (2014-2025)
1.4.8 India CD Antigen Cancer Therapy Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of CD Antigen Cancer Therapy
2.3 Manufacturing Process Analysis of CD Antigen Cancer Therapy
2.4 Industry Chain Structure of CD Antigen Cancer Therapy

3 Development and Manufacturing Plants Analysis of CD Antigen Cancer Therapy
3.1 Capacity and Commercial Production Date
3.2 Global CD Antigen Cancer Therapy Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of CD Antigen Cancer Therapy
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 CD Antigen Cancer Therapy Production and Capacity Analysis
4.2 CD Antigen Cancer Therapy Revenue Analysis
4.3 CD Antigen Cancer Therapy Price Analysis
4.4 Market Concentration Degree

5 CD Antigen Cancer Therapy Regional Market Analysis
5.1 CD Antigen Cancer Therapy Production by Regions
5.1.1 Global CD Antigen Cancer Therapy Production by Regions
5.1.2 Global CD Antigen Cancer Therapy Revenue by Regions
5.2 CD Antigen Cancer Therapy Consumption by Regions
5.3 North America CD Antigen Cancer Therapy Market Analysis
5.3.1 North America CD Antigen Cancer Therapy Production
5.3.2 North America CD Antigen Cancer Therapy Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America CD Antigen Cancer Therapy Import and Export
5.4 Europe CD Antigen Cancer Therapy Market Analysis
5.4.1 Europe CD Antigen Cancer Therapy Production
5.4.2 Europe CD Antigen Cancer Therapy Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe CD Antigen Cancer Therapy Import and Export
5.5 China CD Antigen Cancer Therapy Market Analysis
5.5.1 China CD Antigen Cancer Therapy Production
5.5.2 China CD Antigen Cancer Therapy Revenue
5.5.3 Key Manufacturers in China
5.5.4 China CD Antigen Cancer Therapy Import and Export
5.6 Japan CD Antigen Cancer Therapy Market Analysis
5.6.1 Japan CD Antigen Cancer Therapy Production
5.6.2 Japan CD Antigen Cancer Therapy Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan CD Antigen Cancer Therapy Import and Export
5.7 Southeast Asia CD Antigen Cancer Therapy Market Analysis
5.7.1 Southeast Asia CD Antigen Cancer Therapy Production
5.7.2 Southeast Asia CD Antigen Cancer Therapy Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia CD Antigen Cancer Therapy Import and Export
5.8 India CD Antigen Cancer Therapy Market Analysis
5.8.1 India CD Antigen Cancer Therapy Production
5.8.2 India CD Antigen Cancer Therapy Revenue
5.8.3 Key Manufacturers in India
5.8.4 India CD Antigen Cancer Therapy Import and Export

6 CD Antigen Cancer Therapy Segment Market Analysis (by Type)
6.1 Global CD Antigen Cancer Therapy Production by Type
6.2 Global CD Antigen Cancer Therapy Revenue by Type
6.3 CD Antigen Cancer Therapy Price by Type

7 CD Antigen Cancer Therapy Segment Market Analysis (by Application)
7.1 Global CD Antigen Cancer Therapy Consumption by Application
7.2 Global CD Antigen Cancer Therapy Consumption Market Share by Application (2014-2019)

8 CD Antigen Cancer Therapy Major Manufacturers Analysis
8.1 AryoGen Biopharma
8.1.1 AryoGen Biopharma CD Antigen Cancer Therapy Production Sites and Area Served
8.1.2 AryoGen Biopharma Product Introduction, Application and Specification
8.1.3 AryoGen Biopharma CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Biocad
8.2.1 Biocad CD Antigen Cancer Therapy Production Sites and Area Served
8.2.2 Biocad Product Introduction, Application and Specification
8.2.3 Biocad CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Biogen Idec
8.3.1 Biogen Idec CD Antigen Cancer Therapy Production Sites and Area Served
8.3.2 Biogen Idec Product Introduction, Application and Specification
8.3.3 Biogen Idec CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Celltrion
8.4.1 Celltrion CD Antigen Cancer Therapy Production Sites and Area Served
8.4.2 Celltrion Product Introduction, Application and Specification
8.4.3 Celltrion CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Genentech
8.5.1 Genentech CD Antigen Cancer Therapy Production Sites and Area Served
8.5.2 Genentech Product Introduction, Application and Specification
8.5.3 Genentech CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Genmab
8.6.1 Genmab CD Antigen Cancer Therapy Production Sites and Area Served
8.6.2 Genmab Product Introduction, Application and Specification
8.6.3 Genmab CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 GLYCART Biotechnology
8.7.1 GLYCART Biotechnology CD Antigen Cancer Therapy Production Sites and Area Served
8.7.2 GLYCART Biotechnology Product Introduction, Application and Specification
8.7.3 GLYCART Biotechnology CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Hetero Drugs
8.8.1 Hetero Drugs CD Antigen Cancer Therapy Production Sites and Area Served
8.8.2 Hetero Drugs Product Introduction, Application and Specification
8.8.3 Hetero Drugs CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 mAbxience
8.9.1 mAbxience CD Antigen Cancer Therapy Production Sites and Area Served
8.9.2 mAbxience Product Introduction, Application and Specification
8.9.3 mAbxience CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 MedImmune
8.10.1 MedImmune CD Antigen Cancer Therapy Production Sites and Area Served
8.10.2 MedImmune Product Introduction, Application and Specification
8.10.3 MedImmune CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Merck
8.12 Sandoz
8.13 UCB

9 Development Trend of Analysis of CD Antigen Cancer Therapy Market
9.1 Global CD Antigen Cancer Therapy Market Trend Analysis
9.1.1 Global CD Antigen Cancer Therapy Market Size (Volume and Value) Forecast 2019-2025
9.2 CD Antigen Cancer Therapy Regional Market Trend
9.2.1 North America CD Antigen Cancer Therapy Forecast 2019-2025
9.2.2 Europe CD Antigen Cancer Therapy Forecast 2019-2025
9.2.3 China CD Antigen Cancer Therapy Forecast 2019-2025
9.2.4 Japan CD Antigen Cancer Therapy Forecast 2019-2025
9.2.5 Southeast Asia CD Antigen Cancer Therapy Forecast 2019-2025
9.2.6 India CD Antigen Cancer Therapy Forecast 2019-2025
9.3 CD Antigen Cancer Therapy Market Trend (Product Type)
9.4 CD Antigen Cancer Therapy Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 CD Antigen Cancer Therapy Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of CD Antigen Cancer Therapy
Table Global CD Antigen Cancer Therapy Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global CD Antigen Cancer Therapy Production Market Share by Types in 2018
Figure Monoclonal Antibodies Product Picture
Figure Antibody-Drug-Conjugates Product Picture
Figure Tri-Functional and Bi-Specific T-Cell Engager Antibodies Product Picture
Figure Other Product Picture
Table Global CD Antigen Cancer Therapy Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global CD Antigen Cancer Therapy Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Clinics
Figure Other
Figure Global CD Antigen Cancer Therapy Revenue (Million USD) (2014-2025)
Figure Global CD Antigen Cancer Therapy Production (K Units) (2014-2025)
Figure North America CD Antigen Cancer Therapy Market Size (Million USD) (2014-2025)
Figure Europe CD Antigen Cancer Therapy Market Size (Million USD) (2014-2025)
Figure China CD Antigen Cancer Therapy Market Size (Million USD) (2014-2025)
Figure Japan CD Antigen Cancer Therapy Market Size (Million USD) (2014-2025)
Figure Southeast Asia CD Antigen Cancer Therapy Market Size (Million USD) (2014-2025)
Figure India CD Antigen Cancer Therapy Market Size (Million USD) (2014-2025)
Table CD Antigen Cancer Therapy Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of CD Antigen Cancer Therapy in 2018
Figure Manufacturing Process Analysis of CD Antigen Cancer Therapy
Figure Industry Chain Structure of CD Antigen Cancer Therapy
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global CD Antigen Cancer Therapy Manufacturing Plants Distribution
Table CD Antigen Cancer Therapy Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table CD Antigen Cancer Therapy Capacity (K Units) of Major Manufacturers (2014-2019)
Table CD Antigen Cancer Therapy Production (K Units) of Major Manufacturers (2014-2019)
Table CD Antigen Cancer Therapy Production Market Share of Major Manufacturers (2014-2019)
Figure CD Antigen Cancer Therapy Production Share by Manufacturers in 2018
Table CD Antigen Cancer Therapy Revenue (Million US$) of Major Manufacturers (2014-2019)
Table CD Antigen Cancer Therapy Revenue Market Share of Major Manufacturers (2014-2019)
Figure CD Antigen Cancer Therapy Revenue Share by Manufacturers in 2018
Table CD Antigen Cancer Therapy Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global CD Antigen Cancer Therapy Production by Regions 2014-2019 (K Units)
Table Global CD Antigen Cancer Therapy Production Market Share by Regions 2014-2019
Figure Global CD Antigen Cancer Therapy Production Market Share by Regions in 2018
Table Global CD Antigen Cancer Therapy Revenue by Regions 2014-2019 (Million USD)
Table Global CD Antigen Cancer Therapy Revenue Market Share by Regions 2014-2019
Figure Global CD Antigen Cancer Therapy Revenue Market Share by Regions in 2018
Table Global CD Antigen Cancer Therapy Consumption by Regions 2014-2019 (K Units)
Table Global CD Antigen Cancer Therapy Consumption Market Share by Regions 2014-2019
Figure North America CD Antigen Cancer Therapy Production Growth Rate 2014-2019 (K Units)
Figure North America CD Antigen Cancer Therapy Revenue Growth Rate 2014-2019 (Million USD)
Table North America CD Antigen Cancer Therapy Production, Consumption Import and Export (K Units)
Figure Europe CD Antigen Cancer Therapy Production Growth Rate 2014-2019 (K Units)
Figure Europe CD Antigen Cancer Therapy Revenue Growth Rate 2014-2019 (Million USD)
Table Europe CD Antigen Cancer Therapy Production, Consumption Import and Export (K Units)
Figure China CD Antigen Cancer Therapy Production Growth Rate 2014-2019 (K Units)
Figure China CD Antigen Cancer Therapy Revenue Growth Rate 2014-2019 (Million USD)
Table China CD Antigen Cancer Therapy Production, Consumption Import and Export (K Units)
Figure Japan CD Antigen Cancer Therapy Production Growth Rate 2014-2019 (K Units)
Figure Japan CD Antigen Cancer Therapy Revenue Growth Rate 2014-2019 (Million USD)
Table Japan CD Antigen Cancer Therapy Production, Consumption Import and Export (K Units)
Figure Southeast Asia CD Antigen Cancer Therapy Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia CD Antigen Cancer Therapy Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia CD Antigen Cancer Therapy Production, Consumption Import and Export (K Units)
Figure India CD Antigen Cancer Therapy Production Growth Rate 2014-2019 (K Units)
Figure India CD Antigen Cancer Therapy Revenue Growth Rate 2014-2019 (Million USD)
Table India CD Antigen Cancer Therapy Production, Consumption Import and Export (K Units)
Figure Global Consumption CD Antigen Cancer Therapy Market Share by Application (2014-2019)
Figure Global Value (Consumption) CD Antigen Cancer Therapy Market Share by Application (2014-2019)
Table AryoGen Biopharma CD Antigen Cancer Therapy Production Sites and Area Served
Table AryoGen Biopharma CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table AryoGen Biopharma CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AryoGen Biopharma CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table AryoGen Biopharma CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure AryoGen Biopharma CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table AryoGen Biopharma CD Antigen Cancer Therapy Main Business and Markets Served
Table Biocad CD Antigen Cancer Therapy Production Sites and Area Served
Table Biocad CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table Biocad CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Biocad CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table Biocad CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure Biocad CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table Biocad CD Antigen Cancer Therapy Main Business and Markets Served
Table Biogen Idec CD Antigen Cancer Therapy Production Sites and Area Served
Table Biogen Idec CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table Biogen Idec CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Biogen Idec CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table Biogen Idec CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure Biogen Idec CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table Biogen Idec CD Antigen Cancer Therapy Main Business and Markets Served
Table Celltrion CD Antigen Cancer Therapy Production Sites and Area Served
Table Celltrion CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table Celltrion CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Celltrion CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table Celltrion CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure Celltrion CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table Celltrion CD Antigen Cancer Therapy Main Business and Markets Served
Table Genentech CD Antigen Cancer Therapy Production Sites and Area Served
Table Genentech CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table Genentech CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Genentech CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table Genentech CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure Genentech CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table Genentech CD Antigen Cancer Therapy Main Business and Markets Served
Table Genmab CD Antigen Cancer Therapy Production Sites and Area Served
Table Genmab CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table Genmab CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Genmab CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table Genmab CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure Genmab CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table Genmab CD Antigen Cancer Therapy Main Business and Markets Served
Table GLYCART Biotechnology CD Antigen Cancer Therapy Production Sites and Area Served
Table GLYCART Biotechnology CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table GLYCART Biotechnology CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GLYCART Biotechnology CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table GLYCART Biotechnology CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure GLYCART Biotechnology CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table GLYCART Biotechnology CD Antigen Cancer Therapy Main Business and Markets Served
Table Hetero Drugs CD Antigen Cancer Therapy Production Sites and Area Served
Table Hetero Drugs CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table Hetero Drugs CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Hetero Drugs CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table Hetero Drugs CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure Hetero Drugs CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table Hetero Drugs CD Antigen Cancer Therapy Main Business and Markets Served
Table mAbxience CD Antigen Cancer Therapy Production Sites and Area Served
Table mAbxience CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table mAbxience CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table mAbxience CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table mAbxience CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure mAbxience CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table mAbxience CD Antigen Cancer Therapy Main Business and Markets Served
Table MedImmune CD Antigen Cancer Therapy Production Sites and Area Served
Table MedImmune CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table MedImmune CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table MedImmune CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table MedImmune CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure MedImmune CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table MedImmune CD Antigen Cancer Therapy Main Business and Markets Served
Table Merck CD Antigen Cancer Therapy Production Sites and Area Served
Table Sandoz CD Antigen Cancer Therapy Production Sites and Area Served
Table UCB CD Antigen Cancer Therapy Production Sites and Area Served
Figure Global CD Antigen Cancer Therapy Production (K Units) Growth Rate Forecast 2019-2025
Figure Global CD Antigen Cancer Therapy Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global CD Antigen Cancer Therapy Sales Price (USD/Unit) Forecast 2019-2025
Figure North America CD Antigen Cancer Therapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America CD Antigen Cancer Therapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe CD Antigen Cancer Therapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe CD Antigen Cancer Therapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China CD Antigen Cancer Therapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure China CD Antigen Cancer Therapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan CD Antigen Cancer Therapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan CD Antigen Cancer Therapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia CD Antigen Cancer Therapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia CD Antigen Cancer Therapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India CD Antigen Cancer Therapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure India CD Antigen Cancer Therapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of CD Antigen Cancer Therapy by Type (2019-2025)
Table Global Consumption (K Units) of CD Antigen Cancer Therapy by Application (2019-2025)
Table CD Antigen Cancer Therapy Distributors List
Table CD Antigen Cancer Therapy Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

がん幹細胞療法のグローバル市場調査 2019年

Global Cancer Stem Cell Therapy Market Professional Survey Report 2019
QYR9NV02113 2019年11月12日 105Pages
※本調査レポートは、がん幹細胞療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、自家幹細胞移植、同種幹細胞移植、同系幹細胞移植、その他に、用途別には、病院、...

B細胞成熟抗原（BCMA）標的療法のグローバル市場調査 2019年

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Professional Survey Report 2019
QYR9NV01584 2019年11月12日 110Pages
※本調査レポートは、B細胞成熟抗原（BCMA）標的療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、二重特異性抗体、抗体薬物コンジュゲート、キメラ抗原受容体...

細胞性腫瘍抗原p53のグローバル市場調査 2019年

Global Cellular Tumor Antigen p53 Market Professional Survey Report 2019
QYR9NV02373 2019年11月12日 111Pages
※本調査レポートは、細胞性腫瘍抗原p53の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、COTI-2、D-12PGJ3、APR-246、ATRN-502、セネ...

併用療法薬のグローバル市場調査 2019年

Global Combination Therapy Drug Market Professional Survey Report 2019
QYR9NV02770 2019年11月12日 104Pages
※本調査レポートは、併用療法薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グリチルリチン酸二アンモニウム、インターフェロンおよびヌクレオシド薬、標的療法薬...

子宮頸がんワクチンのグローバル市場調査 2019年

Global Cervical Cancer Vaccine Market Professional Survey Report 2019
QYR9NV02450 2019年11月12日 103Pages
※本調査レポートは、子宮頸がんワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ガーダシル、セルバリックスに、用途別には、HPV6、HPV11、HPV1...

冷間圧迫療法製品のグローバル市場調査 2019年

Global Cold Compression Therapy Product Market Professional Survey Report 2019
QYR9NV02731 2019年11月12日 109Pages
※本調査レポートは、冷間圧迫療法製品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、デバイス、ラップに、用途別には、リハビリテーションセンター、病院＆クリニッ...

カッピング療法キットのグローバル市場調査 2019年

Global Cupping Therapy Kits Market Professional Survey Report 2019
QYR9NV03267 2019年11月12日 107Pages
※本調査レポートは、カッピング療法キットの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、真空カッピング装置、ガラスカッピング装置、竹カッピング装置、電気カッピ...

アンドロゲン補充療法のグローバル市場調査 2019年

Global Androgen Replacement Therapy Market Professional Survey Report 2019
QYR9NV00718 2019年11月12日 113Pages
※本調査レポートは、アンドロゲン補充療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ゲル、注射剤、パッチ、その他に、用途別には、病院、クリニック、その他に...

がん幹細胞療法のグローバル市場調査 2019年 The global Cancer Stem Cell Therapy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cancer Stem Cell Therapy volume and value at global level, regional level and company level. From a global perspec…
がん胎児性抗原（CEA）の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. Scope of the Report: This report studies the Carcinoembryonic Antigen (CEA) market status and outlook of Global and major regions, from angles of players, countries, product types and end indust…
B細胞成熟抗原（BCMA）標的療法のグローバル市場調査 2019年 The global B-Cell Maturation Antigen(BCMA) Targeted Therapies market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on B-Cell Maturation Antigen(BCMA) Targeted Therapies volume and value at global level, reg…
がん遺伝子治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has be…
細胞性腫瘍抗原p53のグローバル市場調査 2019年 The global Cellular Tumor Antigen p53 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cellular Tumor Antigen p53 volume and value at global level, regional level and company level. From a global per…